Trademark: 85040912
Status Date
Monday, January 23, 2012
Filing Date
Monday, May 17, 2010
Published for Opposition
Tuesday, April 26, 2011
Abandoned Date
Monday, January 23, 2012
5 human and veterinary pharmaceuticals for use in the prevention and treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, amylodiosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders
42 Pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials; medical and scientific research in the fields of treatment for cancer and oncology, and in the fields of treatment of inflammation and autoimmune diseases
Jan 23, 2012
Abandonment Notice Mailed - No Use Statement Filed
Jan 23, 2012
Abandonment - No Use Statement Filed
Jun 21, 2011
Noa E-Mailed - Sou Required From Applicant
May 19, 2011
Applicant/Correspondence Changes (Non-Responsive) Entered
May 19, 2011
Teas Change Of Owner Address Received
Apr 26, 2011
Official Gazette Publication Confirmation E-Mailed
Apr 26, 2011
Published For Opposition
Mar 23, 2011
Law Office Publication Review Completed
Mar 23, 2011
Approved For Pub - Principal Register
Mar 23, 2011
Teas/Email Correspondence Entered
Mar 23, 2011
Correspondence Received In Law Office
Mar 15, 2011
Assigned To Lie
Mar 3, 2011
Teas Response To Office Action Received
Sep 3, 2010
Notification Of Priority Action E-Mailed
Sep 3, 2010
Priority Action E-Mailed
Sep 3, 2010
Priority Action Written
Aug 29, 2010
Assigned To Examiner
May 21, 2010
New Application Office Supplied Data Entered In Tram
May 20, 2010
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
